Skip to main content
SpringerLink
Log in
Book cover

Psychiatry and Neuroscience Update pp 187–200Cite as

Lithium Therapy Effects on the Reproductive System

  • Chapter
  • First Online:

Abstract

The chemical properties of lithium (Li) make it an extremely active substance in the body. It is active in the form of Li+ ion, so all salts have the same pharmacological action. Li salts are used to treat manic-depressive disorders (bipolar affective disorders), depressive manic symptoms that include hurried speech, hyperactivity, little need for sleep, aggression, and cholera. Li is a mood stabilizer and reduces extreme behaviors by restoring the balance of neurotransmitters in the brain. The modifications of the cAMP signaling pathway, alterations in the phosphoinositol pathway, and variations in the availability of GABA and glutamate are some described mechanisms of action of Li to achieve its antimanic and mood-stabilizing effects. Thus, Li exerts modifications on the circadian rhythm, neurotransmission processes in the central nervous system, and neuroendocrine functions.

Li therapies have benefits that have not yet been overtaken by other drugs. However, there is also some resistance to using these drugs, partly due to the lack of knowledge of the real impact of its adverse effects although some of them are reversible with the discontinuation of treatment. However, less known and more controversial are the toxic effects of Li therapy on the reproductive system and, therefore, on human sexual functions. Studies in human and laboratory animals on the effects of Li have demonstrated significant effects on the functioning of the hypothalamic-pituitary-gonadal axis. Therefore, this ion may alter human reproduction.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder. J Clin Psychiatry. 2003;64:18–24.

    CAS  PubMed  Google Scholar 

  2. Lin D, Mok H, Yatham LN. Polytherapy in bipolar disorder. CNS Drugs. 2006;20:29–42.

    CAS  PubMed  Google Scholar 

  3. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68(3):241–51.

    PubMed  PubMed Central  Google Scholar 

  4. Murru A, Popovic D, Pacchiarotti I, Hidalgo D, León-Caballero J, Vieta E. Management of adverse effects of mood stabilizers. Curr Psychiatry Rep. 2015;17:66.

    Google Scholar 

  5. Kenna HA, Jiang B, Rasgon NL. Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment. Harv Rev Psychiatry. 2009;17(2):138–46.

    PubMed  Google Scholar 

  6. Kesebir S, Toprak B, Baykaran B, Hariri A, Bilici M. Comparison of sexual function and hormonal parameters between mood stabilizer treatment modalities in bipolar disorder. Arch Neuropsychiatry. 2014;51:242–7.

    Google Scholar 

  7. Manisto PT. Endocrine side-effects of lithium. In: Johnson FN, editor. Handbook of lithium therapy. Baltimore: New York University Park Press; 1980.

    Google Scholar 

  8. Ghosh D, Biswas NM. Effect of lithium chloride on the activities of ovarian delta 5-3 beta and 17b-hydroxysteroid dehydrogenase and histology of ovary in albino rats. Med Sci Res. 1991;19:703.

    CAS  Google Scholar 

  9. Ghosh S, Misro M, Baran D, Maiti U, Mohan R, Debnath J, Ghosh D. Effect of human chorionic gonadotrophin coadministration on ovarian steroidogenic and folliculogenic activities in cyclophosphamide treated albino rats. Reprod Toxicol. 2001;15:221–5.

    CAS  PubMed  Google Scholar 

  10. Joffe M. Semen quality analysis and the idea of normal fertility. Asian J Androl. 2010;12:79–82.

    PubMed  PubMed Central  Google Scholar 

  11. Kusalic M, Engelsmann F. Effect of lithium maintenance treatment on hypothalamic pituitary gonadal axis in bipolar men. J Psychiatry Neurosci. 1996;21(3):181–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. El-Mallakh RS. Ion homeostasis and the mechanism of action of lithium. Clin Neurosci Res. 2004;4:227–31.

    CAS  Google Scholar 

  13. Martín B, López-Muñoz F, Alamo C, Cuenca E. Litio: otras indicaciones terapéuticas. 2001. Available from: http://www.psiquiatria.com/tratamientos/litio-otras-indicaciones-terapeuticas/.

  14. Mármol F. Lithium: bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(8):1761–71.

    PubMed  Google Scholar 

  15. Mitchell PB. On the 50th anniversary of John Cade’s discovery of the anti-manic effect of lithium. Aust N Z J Psychiatry. 1999;33:623–8.

    CAS  PubMed  Google Scholar 

  16. López-Muñoz F, Alamo C, Cuenca E. Sales de litio y otros reguladores del humor. In: López-Muñoz F, Alamo C, editors. Historia de la Neuropsicofarmacología. Madrid: Ediciones Eurobook S.L; 1998. p. 305–16.

    Google Scholar 

  17. Malgor V. Farmacología de las sales de litio. Usos terapéuticos en trastornos bipolares y en la depresión mayor recurrente. In: Temas de Farmacología. 2nd ed. 2000. 5 cap 15:153–161. Available from: http://med.unne.edu.ar/farmaco.html.

  18. Scott IM. The determination of lithium in blood serum by atomic absorption spectrophotometry. J Forensic Sci. 1982;22:41–2.

    CAS  Google Scholar 

  19. Mármol F. Litio: 55 años de historia en el tratamiento del trastorno bipolar. Med Clin (Barc). 2006;127(5):189–95.

    Google Scholar 

  20. Lima TZ, Blanco MM, Santos Júnior JG, Coelho CT, Mello LE. Staying at the crossroads: assessment of the potential of serum lithium monitoring in predicting an ideal lithium dose. Rev Bras Psiquiatr. 2008;30(3):215–21.

    PubMed  Google Scholar 

  21. Severus WE, Kleindienst N, Seemüller F, Frangou S, Möller HJ, Greil W. What is the optimal serum lithium level in the long-term treatment of bipolar disorder – a review? Bipolar Disord. 2008;10:231–7.

    CAS  PubMed  Google Scholar 

  22. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379:721–8.

    CAS  PubMed  Google Scholar 

  23. Malhi GS, Tanious M. Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations. CNS Drugs. 2011;25(4):289–98.

    CAS  PubMed  Google Scholar 

  24. Paton C, Adroer R, Barnes TR. Monitoring lithium therapy: the impact of a quality improvement programme in the UK. Bipolar Disord. 2013;15(8):865–75.

    CAS  PubMed  Google Scholar 

  25. Schou M, Juel-Nielsen N, Ströngren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Psychiatr. 1954;17:250–60.

    CAS  Google Scholar 

  26. Mármol F. Estudio del mecanismo de acción neurofarmacológica del litio en el modelo experimental de plexo mientérico de cobayo. Barcelona: Universitad de Barcelona; 1989.

    Google Scholar 

  27. Belmaker RH. Bipolar disorder. N Engl J Med. 2004;351(5):476–86.

    CAS  PubMed  Google Scholar 

  28. Gershon S, Chengappa KN, Malhi GS. Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord. 2009;11(Suppl 2):34–44.

    CAS  PubMed  Google Scholar 

  29. Thies-Flechner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders: data from a randomized prospective trial. Pharmacopsychiatry. 1996;29:103–7.

    Google Scholar 

  30. Tondo L, Jamison KR, Baldessarini RJ. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann N Y Acad Sci. 1997;836:339–51.

    CAS  PubMed  Google Scholar 

  31. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290:1467–73.

    CAS  PubMed  Google Scholar 

  32. Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for pathophysiology and treatment of manic-depressive illness. Biol Psychiatry. 2000;48:740–54.

    CAS  PubMed  Google Scholar 

  33. Alvano SA. Posibles mecanismos y acciones farmacológicas involucradas en el efecto antimaníaco y estabilizador del humor (Primera parte). Psicofarmacología. 2005;5(30):11–8.

    Google Scholar 

  34. Alda M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry. 2015;20(6):661–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther. 2010;128(2):281–304.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Coppen A. The biochemistry of affective disorders. Br J Psychiatry. 1967;113:1237–64.

    CAS  PubMed  Google Scholar 

  37. El-Mallakh RS, Jefferson JW. Prethymoleptic use of lithium. Am J Psychiatry. 1999;156:1.

    Google Scholar 

  38. Kirshenbaum GS, Clapcote SJ, Duffy S, Burgess CR, Petersen J, Jarowek KJ, Yücel YH, Cortez MA, Snead OC 3rd, Vilsen B, Peever JH, Ralph MR, Roder JC. Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase alpha3 sodium pump. Proc Natl Acad Sci U S A. 2011;108:18144–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Reddy PL, Khanna S, Subhash MN, Channabasavanna SM, Rao BS. Erythrocyte membrane sodium-potassium adenosine triphosphatase activity in affective disorders. J Neural Transm Gen Sect. 1992;89:209–18.

    CAS  PubMed  Google Scholar 

  40. Huang X, Lei Z, El-Mallakh RS. Lithium normalizes elevated intracellular sodium. Bipolar Disord. 2007;9:298–300.

    CAS  PubMed  Google Scholar 

  41. Aperia A. New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. J Intern Med. 2007;261:44–52.

    CAS  PubMed  Google Scholar 

  42. Banerjee U, Dasgupta A, Rout JK, Singh OP. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2012;37:56–61.

    CAS  PubMed  Google Scholar 

  43. Zhang L, Zhang Z, Guo H, Wang Y. Na+/K+-ATPase-mediated signal transduction and Na+/K+-ATPase regulation. Fundam Clin Pharmacol. 2008;22:615–21.

    CAS  PubMed  Google Scholar 

  44. Jope R. Effects of lithium treatment in vitro and in vivo on acetylcholine metabolism in rat brain. J Neurochem. 1979;33:487–95.

    CAS  PubMed  Google Scholar 

  45. Price LH, Heninger GR. Lithium in the treatment of mood disorders. N Engl J Med. 1994;331:591–8.

    CAS  PubMed  Google Scholar 

  46. Grof P, Grof E. Varieties of lithium benefit. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:689–96.

    CAS  PubMed  Google Scholar 

  47. Manji HK, Hsiao JK, Risby ED, Oliver J, Rudorfer MV, Potter WJ. The mechanisms of action of lithium: I: effects on serotoninergic and noradrenergic systems in normal subjects. Arch Gen Psychiatry. 1991;48:505–12.

    CAS  PubMed  Google Scholar 

  48. Akiskal HS, Downs J, Jordan P, Watson S, Daugherty D, Pruitt DB. Affective disorders in referred children and younger siblings of manic-depressives. Arch Gen Psychiatry. 1985;42:996–1003.

    CAS  PubMed  Google Scholar 

  49. Borden C, Valproate, Schatzberg AF, Nemeroff CB. Textbook of psychopharmacology. 3rd ed. Washington, DC: American Psychiatric Publishing; 2004. p. 567–79.

    Google Scholar 

  50. Freeman MP, Wiegand C, Gelenberg AJ. Lithium. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. 3rd ed. Washington, DC: Amaerican Psychiatric Publishing; 2004. p. 547–65.

    Google Scholar 

  51. Manji HK, Lenox RH. Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry. 2000;48:518–30.

    CAS  PubMed  Google Scholar 

  52. Jope RS. Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry. 1999;4:117–28.

    CAS  PubMed  Google Scholar 

  53. Lenox RH, Frazer A. Mechanism of action of antidepressants and mood stabilizers. In: Davis KL, Charney D, Coyle JT, Nemeroff CB, editors. Neuropsychopharmacology, the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 1139–63.

    Google Scholar 

  54. Embi N, Rylatt DB, Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem. 1980;107:519–27.

    CAS  PubMed  Google Scholar 

  55. Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. 2001;359:1–16.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol. 1996;6:1664–8.

    CAS  PubMed  Google Scholar 

  57. O’Brien WT, Klein PS. Validating GSK3 as an in vivo target of lithium action. Biochem Soc Trans. 2009;37:1133–8.

    PubMed  PubMed Central  Google Scholar 

  58. Grimes CA, Jope RS. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem. 2001;78:1219–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Gould TD. Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications. Expert Opin Ther Targets. 2006;10:377–92.

    CAS  PubMed  Google Scholar 

  60. Jope RS. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci. 2003;24:441–3.

    CAS  PubMed  Google Scholar 

  61. Zou Y. Wnt signaling in axon guidance. Trends Neurosci. 2004;27:528–32.

    CAS  PubMed  Google Scholar 

  62. Meffre D, Grenier J, Bernard S, Courtin F, Dudev T, Shackleford G, Jafarian-Tehrani M, Massaad C. Wnt and lithium: a common destiny in the therapy of nervous system pathologies? Cell Mol Life Sci. 2014;71:1123–48.

    CAS  PubMed  Google Scholar 

  63. Gould TD, Chen G, Manji HK. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology. 2004;29:32–8.

    CAS  PubMed  Google Scholar 

  64. Ahn SW, Kim JE, Park KS, Choi WJ, Hong YH, Kim SM, Kim SH, Lee KW, Sung JJ. The neuroprotective effect of the GSK-3beta inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice. J Neurol Sci. 2012;320:1–5.

    CAS  PubMed  Google Scholar 

  65. Beaulieu JM, Caron MG. Looking at lithium: molecular moods and complex behaviour. Mol Interv. 2008;8:230–41.

    CAS  PubMed  Google Scholar 

  66. Sit D. Women and bipolar disorder across the life span. J Am Med Wom Assoc. 2004;59:91–100.

    PubMed  Google Scholar 

  67. Elenitza IM. Endocrinologic adverse effects of psychotropic drugs. Vertex. 2005;16(59):43–8.

    PubMed  Google Scholar 

  68. Kraszewska A, Chlopocka-Wozniak M, Abramowicz M, Sowinski J, Rybakowski JK. A cross-sectional study of thyroid function in 66 patients with bipolar disorder receiving lithium for 10–44 years. Bipolar Disord. 2015;17(4):375–80.

    CAS  PubMed  Google Scholar 

  69. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23:723–33.

    CAS  PubMed  Google Scholar 

  70. Constantiou C, Bolaris S, Valcana T, et al. Acute LiCl-treatment affects the cytoplasmic T4 availability and the expression pattern of thyroid hormone receptors in adult rat cerebral hemispheres. Neurosci Res. 2004;51:235–41.

    Google Scholar 

  71. Extein I, Pottash AL, Gold MS, et al. The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and bipolar depression. Psychiatry Res. 1980;2:199–204.

    CAS  PubMed  Google Scholar 

  72. Lazarus JH, John R, Bennie EH, Chalmers RJ, Crockett G. Lithium therapy and thyroid function a long-term study. Psychol Med. 1981;11:85–92.

    CAS  PubMed  Google Scholar 

  73. Özerdem A, Tunca Z, Çımrın D, Hıdıroğlu C, Ergör G. Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment. Bipolar Disord. 2014;16(1):72–82.

    PubMed  Google Scholar 

  74. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721–8.

    CAS  PubMed  Google Scholar 

  75. Watanabe K, Kikuchi T. Adverse events of psychotropic drugs. Seishin Shinkeigaku Zasshi. 2014;116(4):323–31.

    PubMed  Google Scholar 

  76. Kishore BK, Ecelbarger CM. Lithium: a versatile tool for understanding renal physiology. Am J Physiol Ren Physiol. 2013;304(9):F1139–49.

    CAS  Google Scholar 

  77. Grünfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5:270–6.

    PubMed  Google Scholar 

  78. Trepiccione F, Capasso G, Nielsen S, Christensen BM. Evaluation of cellular plasticity in the collecting duct during recovery from lithium-induced nephrogenic diabetes insipidus. Am J Physiol Ren Physiol. 2013;305(6):F919–29.

    CAS  Google Scholar 

  79. Raja M. Lithium and kidney, 60 years later. Curr Drug Saf. 2011;6:291–303.

    CAS  PubMed  Google Scholar 

  80. Blount MA, Sim JH, Zhou R, Martin CF, Lu W, Sands JM, Klein JD. Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment. Am J Physiol Ren Physiol. 2010;298(3):F601–8.

    CAS  Google Scholar 

  81. Lydiard RB, Gelenberg AJ. Hazards and adverse effects of lithium. Annu Rev Med. 1982;33:327–44.

    CAS  PubMed  Google Scholar 

  82. Gupta MD, Girish, Goyal M, Subhendu M, Tyagi S. Unusual case of syncope in a patient with ischemic heart disease. Ann Noninvasive Electrocardiol. 2014;19(4):395–7.

    PubMed  Google Scholar 

  83. Altinbas K, Guloksuz S, Caglar IM, Caglar FN, Kurt E, Oral ET. Electrocardiography changes in bipolar patients during long-term lithium monotherapy. Gen Hosp Psychiatry. 2014;36(6):694–7.

    PubMed  Google Scholar 

  84. Yeung CK, Chan HH. Cutaneous adverse effects of lithium: epidemiology and management. Am J Clin Dermatol. 2004;5:3–8.

    PubMed  Google Scholar 

  85. Jafferany M. Lithium and psoriasis: what primary care and family physicians should know. Prim Care Companion J Clin Psychiatry. 2008;10(6):435–9.

    PubMed  PubMed Central  Google Scholar 

  86. López-Jaramillo C, et al. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder. J Clin Psychiatry. 2010;71:1055–60.

    PubMed  Google Scholar 

  87. McElroy SL. Obesity in patients with severe mental illness: overview and management. J Clin Psychiatry. 2009;70(Suppl 3):12–21.

    PubMed  Google Scholar 

  88. Jacobson L. Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects. Compr Physiol. 2014;4(2):715–38.

    PubMed  Google Scholar 

  89. Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J. Second generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf. 2006;29:587–98.

    CAS  PubMed  Google Scholar 

  90. Young W. Review of lithium effects on brain and blood. Cell Transplant. 2009;18(9):951–75.

    PubMed  Google Scholar 

  91. Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol. 2011;26(3):130–40.

    PubMed  Google Scholar 

  92. Griffiths JJ, Zarate CA Jr, Rasimas JJ. Existing and novel biological therapeutics in suicide prevention. Am J Prev Med. 2014;47:195–203.

    Google Scholar 

  93. Perez Romera E, Muñoz E, Mohamed F, Dominguez S, Scardapane L, Villegas O, García Aseff S, Guzmán JA. Lithium effect on testicular tissue and spermatozoa of viscacha (Lagostomus maximus maximus). A comparative study with rats. J Trace Elem Med Biol. 2000;14(2):81–3.

    CAS  PubMed  Google Scholar 

  94. Allagui MS, Hfaiedh N, Croute F, Guermazi F, Vincent C, Soleilhavoup JP, ElFeki A. Side effects of low serum lithium concentrations on renal, thyroid, and sexual functions in male and female rats. C R Biol. 2005;328(10–11):900–11.

    CAS  PubMed  Google Scholar 

  95. Sadeghipour H, Dehghani M, Ghasemi M, Riazi K, Asadi S, Ebrahimi F, Honar H, Hajrasouliha AR, Tavakoli S, Sianati S, Dehpour AR. The nonadrenergic noncholinergic-mediated relaxation of corpus cavernosum was impaired in chronic lithium-treated rats: improvement with L-arginine. Eur J Pharmacol. 2008;586(1–3):300–5.

    CAS  PubMed  Google Scholar 

  96. Saad AB, Rjeibi I, Alimi H, Ncib S, Smida A, Zouari N, Zourgui L. Lithium induced, oxidative stress and related damages in testes and heart in male rats: the protective effects of Malva sylvestris extract. Biomed Pharmacother. 2017;86:127–35.

    CAS  PubMed  Google Scholar 

  97. Sheikha SH, LeGate LS, Banerji TK. Lithium suppresses ovariectomy-induced surges in plasma gonadotropins in rats. Life Sci. 1989;44(19):1363–9.

    CAS  PubMed  Google Scholar 

  98. Khodadadi M, Pirsaraei ZA. Disrupting effects of lithium chloride in the rat ovary: involves impaired formation and function of corpus luteum. Middle East Fertil Soc J. 2013;18(1):18–23.

    Google Scholar 

  99. Jana D, Nandi D, Maiti RK, Ghosh D. Effect of human chorionic gonadotrophin coadministration on the activities of ovarian Delta5-3beta-hydroxysteroid dehydrogenase, and 17beta-hydroxysteroid dehydrogenase, and ovarian and uterine histology in lithium chloride-treated albino rats. Reprod Toxicol. 2001;15(2):215–9.

    CAS  PubMed  Google Scholar 

  100. Mirakhori F, Zeynali B, Tafreshi AP, Shirmohammadian A. Lithium induces follicular atresia in rat ovary through a GSK-3β/β-catenin dependent mechanism. Mol Reprod Dev. 2013;80(4):286–96.

    CAS  PubMed  Google Scholar 

  101. Thakur SC, Thakur SS, Chaube SK, Singh SP. Subchronic supplementation of lithium carbonate induces reproductive system toxicity in male rat. Reprod Toxicol. 2003;17(6):683–90.

    CAS  PubMed  Google Scholar 

  102. Strauss B, Gross J. Effect of psychopharmacologic therapy on sexual functioning. Fortschr Neurol Psychiatr. 1984;52:293–301.

    CAS  PubMed  Google Scholar 

  103. Kristensen E. Sexual side effects induced by psychotropic drugs. Dan Med Bull. 2002;49(4):349–52.

    CAS  PubMed  Google Scholar 

  104. Grover S, Ghosh A, Sarkar S, Chakrabarti S, Avasthi A. Sexual dysfunction in clinically stable patients with bipolar disorder receiving lithium. J Clin Psychopharmacol. 2014;34(4):475–82.

    CAS  PubMed  Google Scholar 

  105. Elnazer HY, Sampson A, Baldwin D. Lithium and sexual dysfunction: an under researched area. Hum Psychopharmacol. 2015; https://doi.org/10.1002/hup.2457. Published online in Wiley Online Library (wileyonlinelibrary.com).

    CAS  Google Scholar 

  106. Pfeifer WD, Davis LC, Van der Velde CD. Lithium accumulation in some endocrine tissues. Acta Biol Med Ger. 1976;35:1519–23.

    CAS  PubMed  Google Scholar 

  107. Denef C. Paracrinicity: the story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol. 2008;20(1):1–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  108. Baştürk M, Karaaslan F, Esel E, Sofuoğlu S, Tutuş A, Yabanoğlu I. Effects of short and long-term lithium treatment on serum prolactin levels in patients with bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:315–22.

    PubMed  Google Scholar 

  109. El Khoury A, Tham A, Mathé AA, Aberg-Wistedt A, StainMalmgren R. Decreased plasma prolactin release in euthymic lithium-treated women with bipolar disorder. Neuropsychobiology. 2003;48:14–8.

    PubMed  Google Scholar 

  110. Pacchiarotti I, Murru A, Kotzalidis GD, Mar Bonnin C, Mazzarini L, Colom F, Vieta E. Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice. Eur Neuropsychopharmacol. 2015;25:1045–59.

    CAS  PubMed  Google Scholar 

  111. Rasgon N, Altshuler L, Gudeman D, et al. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry. 2000;61:173–8.

    CAS  PubMed  Google Scholar 

  112. Joffe H, Cohen LS, Suppes T, McLaughlin WL, Lavori P, Adams JM, Hwang CH, Hall JE, Sachs GS. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry. 2006;59(11):1078–86.

    CAS  PubMed  Google Scholar 

  113. Polotsky AJ, Zhu L, Santoro N, Pollard JW. Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium. Hum Reprod. 2009;24(8):1960–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  114. Freeman MP, Gelenberg AJ. Bipolar disorder in women: reproductive events and treatment considerations. Acta Psychiatr Scand. 2005;112:88–96.

    CAS  PubMed  Google Scholar 

  115. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, Donnenfeld AE, Rieder M, Santelli R, Smythe J, Pastuszak A, Einarson T, Koren G. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet. 1992;339(8792):530–3.

    CAS  PubMed  Google Scholar 

  116. Newport DJ, Viguera AC, Beach AJ, Ritchie JC, Cohen LS, Stowe ZN. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatr. 2005;162(11):2162–70.

    PubMed  Google Scholar 

  117. FDA. FDA Drug Safety Communication: antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. 2011. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm243903.htm.

  118. Llewellyn A, Stowe ZN, Strader JR Jr. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry. 1998;59(Suppl 6):57–64; discussion 65.

    CAS  PubMed  Google Scholar 

  119. Frassetto F, Tourneur Martel F, Barjhoux CE, Villier C, Bot BL, Vincent F. Goiter in a newborn exposed to lithium in utero. Ann Pharmacother. 2002;36(11):1745–8.

    PubMed  Google Scholar 

  120. Pinelli JM, Symington AJ, Cunningham KA, Paes BA. Case report and review of the perinatal implications of maternal lithium use. Am J Obstet Gynecol. 2002;187(1):245–9.

    PubMed  Google Scholar 

  121. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161(4):608–20.

    PubMed  Google Scholar 

  122. Diav-Citrin O, Shechtman S, Tahover E, Finkel-Pekarsky V, Arnon J, Kennedy D, Erebara A, Einarson A, Ornoy A. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry. 2014;171(7):785–94.

    PubMed  Google Scholar 

  123. Khan SJ, Fersh ME, Ernst C, Klipstein K, Albertini ES, Lusskin SI. Bipolar disorder in pregnancy and postpartum: principles of management. Curr Psychiatry Rep. 2016;18(2):13.

    PubMed  Google Scholar 

  124. van der Lugt NM, van de Maat JS, van Kamp IL, Knoppert-van der Klein EA, Hovens JG, Walther FJ. Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies. Early Hum Dev. 2012;88(6):375–8.

    PubMed  Google Scholar 

  125. Deligiannidis KM, Byatt N, Freeman MP. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 2014;34(2):244–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  126. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl. 2003;108(s419):1–22.

    Google Scholar 

  127. Dodd S, Berk M. The pharmacology of bipolar disorder during pregnancy and breastfeeding. Expert Opin Drug Saf. 2004;3(3):221–9.

    CAS  PubMed  Google Scholar 

  128. Abrial E, Bétourné A, Etiévant A, Lucas G, Scarna H, Lambás-Señas L, Haddjeri N. Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania. Int J Neuropsychopharmacol. 2014;18(2). pii: pyu031. https://doi.org/10.1093/ijnp/pyu031.

  129. Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther. 2010;128(2):281–304.

    CAS  PubMed  PubMed Central  Google Scholar 

  130. Rowe MK, Chuang DM. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med. 2004;18:1–18.

    Google Scholar 

  131. Wada A, Yokoo H, Yanagita T, Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci. 2005;99:307–21.

    CAS  PubMed  Google Scholar 

  132. Quiroz JA, Machado-Viera R, Zarate CA Jr. Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology. 2010;62:50–60.

    CAS  PubMed  PubMed Central  Google Scholar 

  133. Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W. Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem. 2009;108:1385–98.

    CAS  PubMed  Google Scholar 

  134. Cabrera O, Dougherty J, Singh S, Swiney BS, Farber NB, Noguchi KK. Lithium protects against glucocorticoid induced neural progenitor cell apoptosis in the developing cerebellum. Brain Res. 2014;1545:54–63.

    CAS  PubMed  Google Scholar 

  135. Fan M, Song C, Wang T, Li L, Dong Y, Jin W, Lu P. Protective effects of lithium chloride treatment on repeated cerebral ischemia-reperfusion injury in mice. Neurol Sci. 2015;36:315–21.

    PubMed  Google Scholar 

  136. Dong BT, Guan-Jun Tu GY, Han YX, Chen Y. Lithium enhanced cell proliferation and differentiation of mesenchymal stem cells to neural cells in rat spinal cord. Int J Clin Exp Pathol. 2015;8(3):2473–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  137. Nciri R, Boujbiha MA, Jbahi S, Allagui MS, Elfeki A, Vincent C, Croute F. Cytoskeleton involvement in lithium-induced SH-SY5Y neuritogenesis and the role of glycogen synthase kinase 3β. Aging Clin Exp Res. 2015;27(3):255–63.

    PubMed  Google Scholar 

  138. Rouhani M, Goliaei B, Khodagholi F, Nikoofar A. Antimanic drug sensitizes breast cancer cell line to ionizing radiation. Gen Physiol Biophys. 2014;33:235–42.

    CAS  PubMed  Google Scholar 

  139. Lubner SJ, Kunnimalaiyaan M, Holen KD, Ning L, Ndiaye M, Loconte NK, Mulkerin DL, Schelman WR, Chen H. A preclinical and clinical study of lithium in low-grade neuroendocrine tumors. Oncologist. 2011;16(4):452–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  140. Li L, Song H, Zhong L, Yang R, Yang XQ, Jiang KL, Liu BZ. Lithium chloride promotes apoptosis in human leukemia NB4 cells by inhibiting glycogen synthase kinase-3 beta. Int J Med Sci. 2015;12(10):805–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  141. Novetsky AP, Thompson DM, Zighelboim I, Thaker PH, Powell MA, Mutch DG, Goodfellow PJ. Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer. Int J Gynecol Cancer. 2013;23(2):361–6.

    PubMed  PubMed Central  Google Scholar 

  142. Maeng YS, Lee R, Lee B, Choi SI, Kim EK. Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cells. Sci Rep. 2016;6:20739. https://doi.org/10.1038/srep20739.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Chemistry, Biochemistry and Pharmacy, National University of San Luis, San Luis, Argentina

    Verónica Palmira Filippa & Fabián Heber Mohamed

Authors
  1. Verónica Palmira Filippa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabián Heber Mohamed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabián Heber Mohamed .

Editor information

Editors and Affiliations

  1. Cathedra of Psychopathology, Catholic University of Argentina, Mendoza, Argentina

    Pascual Ángel Gargiulo

  2. Laboratory of Neurosciences and Experimental Psychology, Area of Pharmacology, Department of Pathology, National University of Cuyo, Council of Scientific and Technological Research (CONICET), Mendoza, Argentina

    Humberto Luis Mesones Arroyo

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Filippa, V.P., Mohamed, F.H. (2019). Lithium Therapy Effects on the Reproductive System. In: Gargiulo, P., Mesones Arroyo, H. (eds) Psychiatry and Neuroscience Update . Springer, Cham. https://doi.org/10.1007/978-3-319-95360-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-95360-1_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-95359-5

  • Online ISBN: 978-3-319-95360-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation